Flow Cytometric Immunophenotyping of Peripheral T Cell Neoplasms Using CD3 Gating

Peripheral T cell neoplasms (PTCNs) such as peripheral T cell lymphoma, adult T cell leukemia/lymphoma, and mycosis fungoides are associated with poorer prognoses compared to B cell neoplasms. Hence, an accurate and early diagnosis is necessary for the successful treatment of PTCNs; however, this can be difficult to achieve. In this study, flow cytometric immunophenotyping using CD3 gating was performed retrospectively on 56 samples from 52 patients diagnosed with PTCNs, and the analytical data were compared with the immunohistochemical findings. Abnormal CD3 T cell populations were distinguishable from the normal T cell population, using this CD3 gating strategy.

[1]  E. Reinherz,et al.  Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor , 1983, Nature.

[2]  B. Nathwani,et al.  Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  I. Lorand-Metze,et al.  Adult T-cell leukemia (ATL) with an unusual immunophenotype and a high cellular proliferation rate. , 1996, Leukemia & lymphoma.

[4]  T. Hanafusa,et al.  Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating. , 2005, American journal of clinical pathology.

[5]  T. Barbui,et al.  Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation , 2006, Leukemia.

[6]  L. Ginaldi,et al.  Differential expression of CD3 and CD7 in T‐cell malignancies: a quantitative study by flow cytometry , 1996, British journal of haematology.

[7]  K. Kishi,et al.  Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan. , 2006, Blood.

[8]  Nicola Pimpinelli,et al.  WHO-EORTC classification for cutaneous lymphomas. , 2005, Blood.

[9]  P. Gaulard,et al.  Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). , 1998, Blood.

[10]  H. Fujiwara,et al.  CD8‐positive adult T‐cell leukemia cells with an integrated defective HTLV‐I genome show a paracrine growth to IL‐2 , 1994, American journal of hematology.

[11]  E. Reinherz,et al.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Bagg,et al.  Molecular pathology of leukemia and lymphoma. , 1999, American journal of clinical pathology.

[13]  H. Rappaport,et al.  T‐cell‐rich lymphoproliferative disorders morphologic and immunologic differential diagnoses , 1988, Cancer.

[14]  L. Medeiros,et al.  Overview of the role of molecular methods in the diagnosis of malignant lymphomas. , 1999, Archives of pathology & laboratory medicine.

[15]  A. Hagenbeek,et al.  Detection of Minimal Residual Disease in Acute Leukemia by Flow Cytometry a , 1986, Annals of the New York Academy of Sciences.

[16]  R. Warnke,et al.  Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. , 1985, The American journal of pathology.

[17]  H. Müller-Hermelink,et al.  Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert’s) variant are often derived from CD8+ cytotoxic T-cells , 2004, Virchows Archiv.

[18]  Terry L. Smith,et al.  Prognostic factors and treatment of patients with T‐cell non‐Hodgkin lymphoma , 2005, Cancer.

[19]  C. Civin,et al.  Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis. , 1988, Journal of immunology.

[20]  Y. Yamashita,et al.  Perforin and granzyme expression in cytotoxic T-cell lymphomas. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[21]  F. Behm,et al.  Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. , 2000, Blood.